LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-13.16%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.18B
AUM Growth
+$1.18B
(-7.3%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
8.72%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18
Top Buys
| 1 |
DexCom
DXCM
|
$17.3M |
| 2 |
Manulife Financial
MFC
|
$6.87M |
| 3 |
Glaukos
GKOS
|
$6.71M |
| 4 |
Republic Services
RSG
|
$6.09M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$5.8M |
Top Sells
| 1 |
AbbVie
ABBV
|
$11.7M |
| 2 |
UnitedHealth
UNH
|
$11.6M |
| 3 |
Halozyme
HALO
|
$8.48M |
| 4 |
iRhythm Technologies
IRTC
|
$7.85M |
| 5 |
CRISPR Therapeutics
CRSP
|
$7.72M |
Sector Composition
| 1 | Healthcare | 46.65% |
| 2 | Financials | 13.97% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Technology | 8.36% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Thermo Fisher Scientific
TMO
$186B
| $28.8M | 2.44% |
52,995
-4,596
| -8% | -$2.5M |
|
2
Service Corp International
SCI
$11.1B
| $27.6M | 2.34% |
400,000
-50,000
| -11% | -$3.46M |
|
3
CVS Health
CVS
$92.8B
| $27.4M | 2.32% |
295,169
-41,298
| -12% | -$3.83M |
|
4
Medifast
MED
$154M
| $27.1M | 2.29% |
150,000
-25,000
| -14% | -$4.51M |
|
5
IQVIA
IQV
$32.4B
| $26.5M | 2.24% |
122,124
-17,439
| -12% | -$3.78M |
|
|
LHCG
6
DELISTED
LHC Group LLC
LHCG
| $25.7M | 2.18% |
165,000
-35,000
| -18% | -$5.45M |
|
7
Bristol-Myers Squibb
BMY
$96B
| $22.6M | 1.91% |
293,631
-64,667
| -18% | -$4.98M |
|
|
8
UnitedHealth
UNH
$281B
| $22.3M | 1.89% |
43,431
-22,525
| -34% | -$11.6M |
|
9
Ameriprise Financial
AMP
$48.5B
| $21.5M | 1.82% |
90,448
-530
| -0.6% | -$126K |
|
|
CIXX
10
DELISTED
CI Financial Corp.
CIXX
| $21.1M | 1.78% |
2,000,000
+250,000
| +14% | +$2.63M |
|
11
BioNTech
BNTX
$24B
| $21M | 1.78% |
140,958
+21,647
| +18% | +$3.23M |
|
12
Neurocrine Biosciences
NBIX
$13.8B
| $21M | 1.77% |
214,930
+24,362
| +13% | +$2.37M |
|
13
Hologic
HOLX
$14.9B
| $21M | 1.77% |
302,309
-41,516
| -12% | -$2.88M |
|
14
Incyte
INCY
$16.5B
| $20.8M | 1.76% |
273,821
-58,677
| -18% | -$4.46M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $20.8M | 1.76% |
250,517
-41,353
| -14% | -$3.43M |
|
|
16
AbbVie
ABBV
$372B
| $20.8M | 1.76% |
135,486
-76,474
| -36% | -$11.7M |
|
17
Thor Industries
THO
$5.79B
| $20.6M | 1.74% |
275,000
| – | – |
|
18
Visa
V
$683B
| $20.1M | 1.7% |
102,102
-20,760
| -17% | -$4.09M |
|
|
19
DexCom
DXCM
$29.5B
| $19.6M | 1.66% |
262,864
+231,600
| +741% | +$17.3M |
|
20
Labcorp
LH
$23.1B
| $18.9M | 1.6% |
80,716
-10,000
| -11% | -$2.34M |
|
|
21
Halozyme
HALO
$8.56B
| $18.5M | 1.57% |
421,403
-192,687
| -31% | -$8.48M |
|
22
Lowe's Companies
LOW
$145B
| $18.4M | 1.56% |
105,480
+1,164
| +1% | +$203K |
|
23
Abbott
ABT
$231B
| $18.3M | 1.55% |
168,777
+11,285
| +7% | +$1.23M |
|
24
Brunswick
BC
$4.15B
| $18M | 1.52% |
275,000
-35,037
| -11% | -$2.29M |
|
25
Equity Lifestyle Properties
ELS
$11.7B
| $17.6M | 1.49% |
250,000
-50,000
| -17% | -$3.52M |
|